Canada · Health Canada Drug Product Database

MAVIRET

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
95591
DIN
02467550
Form
Tablet
Company as listed by source
ABBVIE CORPORATION
Source status
Marketed (2017-09-13)
Source last updated
2026-02-10

Source-listed ingredients

  • PIBRENTASVIR — 40 MG
  • GLECAPREVIR — 100 MG

These values do not establish equivalence or a dose recommendation.

Packages

  • 21/84

Source and coverage

Open Health Canada Drug Product Database

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse Canada records →